Guzmán-Martín, José LuisNavarro-Marí, José MaríaExpósito-Ruiz, ManuelaGutiérrez-Fernández, José2023-01-252023-01-252018http://hdl.handle.net/10668/12474We investigated the reliability of nalidixic acid (NA) susceptibility as a marker of ciprofloxacin susceptibility in Salmonella, analysing 302 stool isolates. NC53 of the MicroScan system was used for NA susceptibility tests and the E-test was used for ciprofloxacin susceptibility tests. Among the isolates, 178 (58.9 %) were serogroup B, 74 (24.5 %) were serogroup D, 27 (8.9 %) were serogroup C and 23 (7.6 %) were from other minor serogroups. Globally, susceptibility to NA correctly predicted the susceptibility of Salmonella to ciprofloxacin, with a sensitivity of 81.5 %, a specificity of 97.6 %, and positive and negative predictive values of 88 and 96 %, respectively. However, there were differences among the serogroups in terms of sensitivity (PenSalmonellaciprofloxacinenteritisnalidixic acidstoolsAnti-Bacterial AgentsCiprofloxacinDrug Resistance, BacterialFecesHumansMicrobial Sensitivity TestsNalidixic AcidSalmonellaSalmonella InfectionsSerogroupresearch article29767616open access10.1099/jmm.0.0007551473-5644https://doi.org/10.1099/jmm.0.000755